Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 116
Filter
1.
BMC Med Educ ; 22(1): 332, 2022 Apr 29.
Article in English | MEDLINE | ID: covidwho-1951177

ABSTRACT

BACKGROUND: Microcredentials (MCs) are short courses that certify/recognise an individual's achievement of specific skills or knowledge. Schools of pharmacy could be well-placed to contribute to the continuing professional development (CPD) of pharmacists through the inclusion of MCs training in their programs. This study aimed to explore pharmacy professionals' views on the need and viability of MC courses globally. METHODS: Eleven semi-structured telephone interviews were conducted with pharmacy practitioners, policymakers, and academics across seven countries. The participants were selected using purposive sampling to explore information from varying pharmacy disciplines. Interviews were audio-recorded, transcribed verbatim, and analysed using a general inductive approach. RESULTS: Participants regarded MCs in pharmacy as an innovative idea, well-suited to the increasingly technology-driven world. They believe MCs provide easily accessible means of skills and knowledge acquisition that fulfils the needs of the pharmacy profession. MCs were also perceived as an alternative pathway of meeting the requirements of traditional CPD programmes. Many participants believe universities are well-suited to provide MCs; however, numerous challenges such as recognition, time and resources have been identified as potential barriers to enrolment and implementation. CONCLUSIONS: This study provides an insight into the views of pharmacy practitioners and academics on MCs, and their potential utility in pharmacy education and practice. The findings should help in the development of MCs that could be utilised by pharmacy practitioners around the world for CPD purposes. This study comes at a time when alternative models of teaching and learning are being explored as a direct result of the COVID-19 pandemic.


Subject(s)
COVID-19 , Pharmaceutical Services , Pharmacy , COVID-19/epidemiology , Humans , Pandemics , Pharmacists
2.
J Am Pharm Assoc (2003) ; 62(4): 929-935, 2022.
Article in English | MEDLINE | ID: covidwho-1936710
3.
BMJ Open ; 12(6): e061917, 2022 06 21.
Article in English | MEDLINE | ID: covidwho-1902021

ABSTRACT

INTRODUCTION: Rheumatoid arthritis (RA) generally requires lifelong treatment; however, its medication complexity might affect non-adherence. Pharmacist-led telehealth services were as effective as face-to-face services and reduced potential side effects in outpatients with chronic diseases. This study aims to analyse the effect of a telepharmacy service with a customised mobile device in comparison with the usual pharmacist service on the humanistic and clinical outcomes in patients with RA. METHODS AND ANALYSIS: The study is designed as a prospective, randomised, open-label, and controlled trial to compare the humanistic and clinical outcomes of the pharmaceutical care service with monthly telecommunications and a customised mobile application (telepharmacy care group) against the usual service by community pharmacists (usual care group) in 256 patients with RA and prescribed at least one of the disease-modifying antirheumatic drugs. Participants will be recruited from a tertiary hospital in Republic of Korea with written informed consent. The primary outcome will be the changes in health-related quality of life as measured by the Korean version of the EuroQoL's five-dimensional questionnaire at 6 months compared with baseline. The secondary outcomes will be the changes in the following: scores of the Korean version of the Compliance Questionnaire-Rheumatology and medication knowledge at 3 and 6 months compared with baseline; scores of the Korean version of the Pharmacy Service Questionnaire at 6 months compared with baseline; clinical parameters such as erythrocyte sedimentation rate, C reactive protein level, and pain score at 3 and 6 months compared with baseline; frequency of acute care utilisation over 6 months. Analysis will be carried out with intent-to-treat and per-protocol principles. ETHICS AND DISSEMINATION: The study protocol was reviewed and approved by the Institutional Review Board (IRB) of Daegu Catholic University Medical Center (IRB no. CR-21-082-L, 14 July 2021). The study findings will be published in peer-reviewed journals. TRIAL REGISTRATION NUMBER: KCT0006508.


Subject(s)
Arthritis, Rheumatoid , Pharmaceutical Services , Arthritis, Rheumatoid/drug therapy , Computers, Handheld , Humans , Prospective Studies , Quality of Life , Randomized Controlled Trials as Topic
4.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887386

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
5.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887385

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
6.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887384

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
7.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887383

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
8.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887382

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
9.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887381

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
10.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887380

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
11.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887379

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
12.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887378

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
13.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887377

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
14.
J Manag Care Spec Pharm ; 28(3-a Suppl): S1-S104, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1887376

ABSTRACT

AMCP 2022 will be held March 29-April 1, 2022 in Chicago Illinois. The AMCP abstracts program provides a forum through which authors can share their insights and outcomes of advanced managed care practice. Podium presentations for the Platinum award-winning abstracts are Wednesday, March 30, from 10:00 am to 11:15 am. Poster presentations are scheduled for Thursday, March 31, from 12:00 pm to 2:30 pm. Posters will be on display on Wednesday March 30, from 4:00 pm to 7:00 pm at the Opening Reception, located at the McCormick Place Convention Center, Lakeside Center. Posters will also be on display on Friday, April 1 from 9:30 am to 11:00 am.


Subject(s)
Pharmaceutical Services , Pharmacies , Pharmacy , Academies and Institutes , Humans , Managed Care Programs
15.
Am J Health Syst Pharm ; 79(10): 720-722, 2022 05 06.
Article in English | MEDLINE | ID: covidwho-1840036
16.
Am J Health Syst Pharm ; 79(16): 1393-1396, 2022 08 05.
Article in English | MEDLINE | ID: covidwho-1831002
17.
Am J Health Syst Pharm ; 79(16): 1369-1375, 2022 08 05.
Article in English | MEDLINE | ID: covidwho-1831000

ABSTRACT

PURPOSE: The purpose of this study was to quantify the growth and trends in postgraduate year 2 (PGY2) pharmacy residencies. METHODS: Summaries of the American Society of Health-System Pharmacists (ASHP) Resident Matching Program from 2008 to 2021 were obtained. Only standalone PGY2 residencies were included in the analysis. Descriptive analyses were completed for data related to the programs and positions. RESULTS: From 2008 to 2021, the total number of ASHP-accredited PGY2 programs increased from 282 to 1,131 (301%) and the overall number of unfilled positions decreased from 22% (77 of 351) to 2% (34 of 1,492). The percentage of positions filled early increased from 23% (81 of 351) to 40% (594 of 1,492) during this time. In 2021, programs with a clinical focus accounted for 91.6% of total positions. The Ambulatory Care category accounted for the largest percentage of all PGY2 residency positions, at 19.2% (287 of 1,492) in 2021 compared to 12.8% (45 of 351) in 2008. The total share of PGY2 residency positions in the Critical Care category decreased from 22.8% (80 of 351) in 2008 to 13.7% (205 of 1,492) in 2021; however, the share of PGY2 residency positions in the Emergency Medicine category increased from 1.4% (5 of 351) to 5.9% (88 of 1,492). CONCLUSION: From 2008 to 2021 the total number of PGY2 residencies increased; however, this growth was uneven, as the share of positions within individual residency categories changed. It is important for pharmacy stakeholders to review the current state of postgraduate training and ensure it reflects the goals for future practice.


Subject(s)
Education, Pharmacy, Graduate , Pharmaceutical Services , Pharmacy Residencies , Students, Pharmacy , Humans , Pharmacists , United States
18.
J Am Pharm Assoc (2003) ; 62(3): 877-882, 2022.
Article in English | MEDLINE | ID: covidwho-1828770

ABSTRACT

PURPOSE: To evaluate inpatient and infusion pharmacist order verification productivity when working from home and to report their perceptions of a flexible workplace setting. METHODS: Order verification data were pulled from the electronic medical record from April 27, 2020, to June 30, 2020, matched to the pharmacist schedule on the basis of work setting and reported as average orders verified per day. Pharmacist perceptions were gathered via a survey to evaluate practice setting background, workplace setting preference, and perceived changes in workflow and their productivity. RESULTS: There was an overall increase in order verification productivity when working from home. Inpatient pharmacists, on average, verified 152 orders per day from home and 133 orders per day onsite. Infusion pharmacists, on average, verified 144 orders per day working from home and 117 orders per day working onsite. Fifty-nine percent of pharmacists reported preferring the mix of onsite and home workplace setting and noted little change in workflow. In addition, 57% of the pharmacists perceived themselves as being more productive, 32% as maintaining the same level of productivity, and 10% felt that they are less productive when working from home. The order verification data showed a greater increase in productivity for infusion shifts worked from home than inpatient shifts. CONCLUSION: The coronavirus 2019 pandemic prompted pharmacy departments to re-evaluate their ability to provide an option for a flexible workplace for pharmacists. Our study demonstrates that pharmacists, on average, verified more orders when working from home, and they also perceive themselves as being more productive. The results of this study support long-term applicability of a flexible work schedule for inpatient and infusion pharmacists.


Subject(s)
Coronavirus , Neoplasms , Pharmaceutical Services , Electronic Health Records , Humans , Inpatients , Pharmacists
19.
Am J Health Syst Pharm ; 79(8): e96, 2022 04 01.
Article in English | MEDLINE | ID: covidwho-1795387

ABSTRACT

This article has been withdrawn due to a publisher error that caused the article to be duplicated. The definitive version of this article is published under DOI 10.1093/ajhp/zxab063.


Subject(s)
COVID-19 , Pharmaceutical Services , Pharmacy , Ambulatory Care , Humans , Pandemics
20.
BMC Med Inform Decis Mak ; 22(1): 99, 2022 04 13.
Article in English | MEDLINE | ID: covidwho-1789119

ABSTRACT

BACKGROUND: Following the coronavirus disease 2019 (COVID-19) pandemic, the health authorities recommended the implementation of strict social distancing and complete lockdown regulations to reduce disease spread. The pharmacists quickly adopted telemedicine (telepharmacy) as a solution against this crisis, but awareness about this technology is lacking. Therefore, the purpose of this research was to explore the patients' perspectives and preferences regarding telepharmacy instead of traditional in-person visits. METHODS: An electronic questionnaire was designed and sent to 313 patients who were eligible for the study (from March to April 2021). The questionnaire used five-point Likert scales to inquire about motivations for adopting telepharmacy and in-person visits, their perceived advantages and disadvantages, and the declining factors of telepharmacy. Finally, the results were descriptively analyzed using SPSS 22. RESULTS: Of all 313 respondents, a total of 241 (77%) preferred appointments via telepharmacy while 72 (23%) preferred in-person services. There was a significant difference between the selection percentage of telepharmacy and in-person services (chi-square 91.42; p < 0.0001). Preference bout the telepharmacy system versus in-person visits to the pharmacy was associated with factors such as "reducing the incidence of contagious disease" (4.41; ± 0.78), "spending less time receiving pharmaceutical services" (4.24; ± 0.86)), and "traveling a shorter distance for receiving pharmaceutical services" (4.25; ± 0.86). "Reducing costs" (90.87%), "saving time" (89.21%), and "reducing the incidence of contagious disease" (87.13%) were the most important reasons for choosing telepharmacy services. Also, "face-to-face communication with the pharmacist" (25%), "low internet bandwidth" (25%), and "reduction of patients' anxiety and the increase of their peace of mind" (23.61%) were the most important reasons for choosing in-person visits. CONCLUSION: Survey data indicate that most participants are likely to prefer the use of telepharmacy, especially during crises such as the current COVID-19 pandemic. Telepharmacy can be applied as an important means and a crucial service to lessen the load on healthcare organizations and expand drug supply shelters in pharmacies. However, there are still substantial hurdles to overcome in order to successfully implement the telemedicine platform as part of mainstream practice.


Subject(s)
COVID-19 , Pharmaceutical Services , Pharmacies , Pharmacy , Telemedicine , COVID-19/epidemiology , COVID-19/prevention & control , Communicable Disease Control , Feasibility Studies , Humans , Pandemics/prevention & control , Surveys and Questionnaires , Telemedicine/methods
SELECTION OF CITATIONS
SEARCH DETAIL